CNS Pharmaceuticals (CNSP) said Wednesday it will implement a 1-for-50 reverse stock split to raise the company's per-share trading price and ensure compliance with Nasdaq's minimum share price listing requirement.
The company said its common stock will start trading on a split-adjusted basis on Nasdaq on Friday.
Shares of CNS Pharmaceuticals fell over 33% in recent trading.
Price: 0.10, Change: -0.05, Percent Change: -33.33
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。